TransMedics Group, Inc.
TMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,827 | $4,545 | $2,269 | $2,094 |
| - Cash | $466 | $401 | $310 | $337 |
| + Debt | $519 | $519 | $518 | $518 |
| Enterprise Value | $3,881 | $4,663 | $2,477 | $2,276 |
| Revenue | $144 | $157 | $144 | $122 |
| % Growth | -8.6% | 9.6% | 18% | – |
| Gross Profit | $85 | $97 | $88 | $72 |
| % Margin | 58.8% | 61.4% | 61.5% | 59.2% |
| EBITDA | $33 | $46 | $36 | $16 |
| % Margin | 23.2% | 29.5% | 25.3% | 13.4% |
| Net Income | $24 | $35 | $26 | $7 |
| % Margin | 16.9% | 22.2% | 17.9% | 5.6% |
| EPS Diluted | 0.66 | 0.92 | 0.7 | 0.19 |
| % Growth | -28.3% | 31.4% | 268.4% | – |
| Operating Cash Flow | $70 | $92 | -$3 | $20 |
| Capital Expenditures | -$8 | -$9 | -$27 | -$14 |
| Free Cash Flow | $62 | $83 | -$30 | $6 |